Horizon Technology Finance Corp (HRZN) 14.27 $HRZN
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2015 Totaling $0.345 Per Share
GlobeNewswire - Tue Nov 04, 3:06PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that its board of directors declared monthly cash distributions of $0.115 per share payable in each of January, February and March 2015. These monthly distributions, payable as set forth in the table below, total $0.345 per share. Including the monthly distributions declared in the fourth quarter of 2014, Horizon has declared $6.305 per share in cumulative distributions since its October 2010 initial public offering.
HRZN: 14.27 (+0.13)
Horizon Technology Finance Announces Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 3:05PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today announced its financial results for the third quarter ended September 30, 2014.
HRZN: 14.27 (+0.13)
Horizon Technology Finance Receives SBA "Green Light" Letter
GlobeNewswire - Mon Nov 03, 7:37AM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced the receipt of a "green light" letter from the U.S. Small Business Administration ("SBA" inviting Horizon to continue its application process to obtain a license to form and operate a Small Business Investment Company ("SBIC" subsidiary.
HRZN: 14.27 (+0.13)
Buy-Rated Dividend Stocks In The Top 3: KCAP, HRZN, SJT
at The Street - Wed Oct 29, 10:31AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
SJT: 18.96 (-0.04), KCAP: 7.63 (+0.13), HRZN: 14.27 (+0.13)
Horizon Technology Finance to Announce Third Quarter 2014 Financial Results
eTeligis - Tue Oct 21, 3:16PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/21/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) (the "Company" or "Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Tuesday, November 4, 2014, after the close of market trading.
HRZN: 14.27 (+0.13)
Buy-Rated Dividend Stocks In The Top 3: AB, CRT, HRZN
at The Street - Mon Oct 20, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
CRT: 27.28 (-0.12), AB: 26.25 (+0.50), HRZN: 14.27 (+0.13)
ZetrOZ, Inc. Announces $5 Million Venture Loan Facility From Horizon Technology Finance to Fuel Expansion Into Amateur Athlete and Chronic Pain Markets
Marketwired - Fri Oct 17, 9:31AM CDT
ZetrOZ, Inc. today announced that it has received a $5 million venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries.
HRZN: 14.27 (+0.13)
Horizon Technology Finance Provides Investment Portfolio Update for Third Quarter 2014
eTeligis - Wed Oct 08, 3:15PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/08/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon", a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today provided a portfolio update for the third quarter of 2014.
HRZN: 14.27 (+0.13)
Horizon Technology Finance Leads Venture Loan Facility for InVisage Technologies
eTeligis - Mon Oct 06, 3:16PM CDT
FARMINGTON, CT and MENLO PARK, CA, United States, via ETELIGIS INC., 10/06/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon", a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a venture loan facility, in which Square 1 Bank participated, for InVisage Technologies, Inc. ("InVisage", an advanced materials & imaging platform company. InVisage will use the funds primarily for working capital purposes.
HRZN: 14.27 (+0.13)
Argos Therapeutics Enters Into $25 Million Venture Loan Facility Led by Horizon Technology Finance
GlobeNewswire - Tue Sep 30, 8:20AM CDT
Argos Therapeutics, Inc. (Nasdaq:ARGS) ("Argos", a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform, today announced that it has entered into a $25 million venture loan led by Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon". Argos plans to devote the loan proceeds to the continuing development of AGS-003, the company's lead oncology product candidate, currently being evaluated in the pivotal ADAPT phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC), and further development of its Arcelis technology platform, including the leasing, build-out and equipping of Argos's planned automated commercial manufacturing facility, and general corporate purposes.
ARGS: 8.48 (-0.21), HRZN: 14.27 (+0.13)
Horizon Technology Finance to Present at the 2014 JMP Securities Financial Services and Real Estate Conference
Marketwire - Tue Sep 23, 3:15PM CDT
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon", a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced that Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer, and Christopher M. Mathieu, Chief Financial Officer, are scheduled to present and participate in one-on-one investor meetings at the 2014 JMP Securities Financial Services and Real Estate Conference. The conference will be held at The St. Regis in New York, with the presentation at 1:00 p.m. ET on Tuesday, September 30, 2014. The accompanying slide presentation will be available in the "Events & Presentations" section of Horizon's website, www.horizontechnologyfinancecorp.com/events.cfm.
HRZN: 14.27 (+0.13)
Horizon Technology Finance Leads $10 Million Venture Loan for IntegenX
Marketwire - Mon Sep 22, 3:35PM CDT
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon", a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a $10 million venture loan for IntegenX Inc. ("IntegenX", the market leader in Rapid Human DNA identification technology. The venture loan was fully funded at closing, with Horizon, Square 1 Bank and a third lender funding their commitments of $3.75 million, $2.5 million, and $3.75 million, respectively. IntegenX will use the funds primarily for working capital purposes.
HRZN: 14.27 (+0.13)
3 Buy-Rated Dividend Stocks To Check Out: SUNS, HRZN, CRT
at The Street - Mon Sep 22, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
CRT: 27.28 (-0.12), SUNS: 15.44 (+0.12), HRZN: 14.27 (+0.13)
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: CXE, GHI, HRZN
at The Street - Mon Sep 15, 9:06AM CDT
CXE GHI HRZN are going ex-dividend tomorrow, Tuesday, September 16, 2014
GHI: 9.50 (-0.03), CXE: 4.86 (+0.02), HRZN: 14.27 (+0.13)
Best Of The Buy-Rated Dividend Stocks: Top 3 Companies: TCPC, HRZN, DOM
at The Street - Tue Sep 02, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
DOM: 7.53 (+0.13), TCPC: 16.93 (+0.28), HRZN: 14.27 (+0.13)
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2015 Totaling $0.345 Per Share
GlobeNewswire - Tue Nov 04, 3:06PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that its board of directors declared monthly cash distributions of $0.115 per share payable in each of January, February and March 2015. These monthly distributions, payable as set forth in the table below, total $0.345 per share. Including the monthly distributions declared in the fourth quarter of 2014, Horizon has declared $6.305 per share in cumulative distributions since its October 2010 initial public offering. HRZN: 14.27 (+0.13)
Horizon Technology Finance Announces Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 3:05PM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today announced its financial results for the third quarter ended September 30, 2014. HRZN: 14.27 (+0.13)
Horizon Technology Finance Receives SBA "Green Light" Letter
GlobeNewswire - Mon Nov 03, 7:37AM CST
Horizon Technology Finance Corporation (Nasdaq:HRZN) (the "Company" or "Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced the receipt of a "green light" letter from the U.S. Small Business Administration ("SBA" inviting Horizon to continue its application process to obtain a license to form and operate a Small Business Investment Company ("SBIC" subsidiary. HRZN: 14.27 (+0.13)
Buy-Rated Dividend Stocks In The Top 3: KCAP, HRZN, SJT
at The Street - Wed Oct 29, 10:31AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
SJT: 18.96 (-0.04), KCAP: 7.63 (+0.13), HRZN: 14.27 (+0.13)
Horizon Technology Finance to Announce Third Quarter 2014 Financial Results
eTeligis - Tue Oct 21, 3:16PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/21/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) (the "Company" or "Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that it plans to release financial results for the third quarter ended September 30, 2014 on Tuesday, November 4, 2014, after the close of market trading. HRZN: 14.27 (+0.13)
Buy-Rated Dividend Stocks In The Top 3: AB, CRT, HRZN
at The Street - Mon Oct 20, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
CRT: 27.28 (-0.12), AB: 26.25 (+0.50), HRZN: 14.27 (+0.13)
ZetrOZ, Inc. Announces $5 Million Venture Loan Facility From Horizon Technology Finance to Fuel Expansion Into Amateur Athlete and Chronic Pain Markets
Marketwired - Fri Oct 17, 9:31AM CDT
ZetrOZ, Inc. today announced that it has received a $5 million venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. HRZN: 14.27 (+0.13)
Horizon Technology Finance Provides Investment Portfolio Update for Third Quarter 2014
eTeligis - Wed Oct 08, 3:15PM CDT
FARMINGTON, CT, United States, via ETELIGIS INC., 10/08/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"
, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, today provided a portfolio update for the third quarter of 2014. HRZN: 14.27 (+0.13)
Horizon Technology Finance Leads Venture Loan Facility for InVisage Technologies
eTeligis - Mon Oct 06, 3:16PM CDT
FARMINGTON, CT and MENLO PARK, CA, United States, via ETELIGIS INC., 10/06/2014 - - Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"
, a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a venture loan facility, in which Square 1 Bank participated, for InVisage Technologies, Inc. ("InVisage", an advanced materials & imaging platform company. InVisage will use the funds primarily for working capital purposes. HRZN: 14.27 (+0.13)
Argos Therapeutics Enters Into $25 Million Venture Loan Facility Led by Horizon Technology Finance
GlobeNewswire - Tue Sep 30, 8:20AM CDT
Argos Therapeutics, Inc. (Nasdaq:ARGS) ("Argos"
, a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology platform, today announced that it has entered into a $25 million venture loan led by Horizon Technology Finance Corporation (Nasdaq:HRZN) ("Horizon". Argos plans to devote the loan proceeds to the continuing development of AGS-003, the company's lead oncology product candidate, currently being evaluated in the pivotal ADAPT phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC), and further development of its Arcelis technology platform, including the leasing, build-out and equipping of Argos's planned automated commercial manufacturing facility, and general corporate purposes. ARGS: 8.48 (-0.21), HRZN: 14.27 (+0.13)
Horizon Technology Finance to Present at the 2014 JMP Securities Financial Services and Real Estate Conference
Marketwire - Tue Sep 23, 3:15PM CDT
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"
, a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced that Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer, and Christopher M. Mathieu, Chief Financial Officer, are scheduled to present and participate in one-on-one investor meetings at the 2014 JMP Securities Financial Services and Real Estate Conference. The conference will be held at The St. Regis in New York, with the presentation at 1:00 p.m. ET on Tuesday, September 30, 2014. The accompanying slide presentation will be available in the "Events & Presentations" section of Horizon's website, www.horizontechnologyfinancecorp.com/events.cfm. HRZN: 14.27 (+0.13)
Horizon Technology Finance Leads $10 Million Venture Loan for IntegenX
Marketwire - Mon Sep 22, 3:35PM CDT
Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"
, a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and cleantech industries, today announced it led a $10 million venture loan for IntegenX Inc. ("IntegenX", the market leader in Rapid Human DNA identification technology. The venture loan was fully funded at closing, with Horizon, Square 1 Bank and a third lender funding their commitments of $3.75 million, $2.5 million, and $3.75 million, respectively. IntegenX will use the funds primarily for working capital purposes. HRZN: 14.27 (+0.13)
3 Buy-Rated Dividend Stocks To Check Out: SUNS, HRZN, CRT
at The Street - Mon Sep 22, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
CRT: 27.28 (-0.12), SUNS: 15.44 (+0.12), HRZN: 14.27 (+0.13)
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: CXE, GHI, HRZN
at The Street - Mon Sep 15, 9:06AM CDT
CXE GHI HRZN are going ex-dividend tomorrow, Tuesday, September 16, 2014
GHI: 9.50 (-0.03), CXE: 4.86 (+0.02), HRZN: 14.27 (+0.13)
Best Of The Buy-Rated Dividend Stocks: Top 3 Companies: TCPC, HRZN, DOM
at The Street - Tue Sep 02, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
DOM: 7.53 (+0.13), TCPC: 16.93 (+0.28), HRZN: 14.27 (+0.13)
